ArticleJournal of neuro-oncology2019

Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function.

Hillary G Caruso et al.PubMed ↗Publisher ↗

No numbers read from the abstract.